This paper presents an experimental study
of three bioreactor configurations. The bioreactor
is intended to be used for the development
of tissue-engineered heart valve substitutes.
Therefore it must be able to reproduce
physiological flow and pressure waveforms
accurately. A detailed analysis of three bioreactor
arrangements is presented using mathematical
models based on the windkessel (WK)
approach. First, a review of the many applications
of this approach in medical studies
enhances its fundamental nature and its usefulness.
Then the models are developed with
reference to the actual components of the
bioreactor. This study emphasizes different
conflicting issues arising in the design
process of a bioreactor for biomedical purposes,
where an optimization process is essential to reach a compromise satisfying all conditions.
Two important aspects are the need for
a simple system providing ease of use and
long-term sterility, opposed to the need for an
advanced (thus more complex) architecture
capable of a more accurate reproduction of the
physiological environment. Three classic WK
architectures are analyzed, and experimental
results enhance the advantages and limitations
of each one.
Bioreactor, design, heart valve, tissue engineering, windkessel models.
Jean Ruel, 1026 avenue de la Médecine, Pavillon Pouliot, office 1361, Québec, PQ, GIV 0A6, Canada. E-mail: jruel@gmc.ulaval.ca
We wish to thank our great
team of collaborators, Yvan Maciel, professor at
Laval University’s Department of Mechanical
Engineering, Dr François Auger and Dr Lucie
Germain, professors at Laval University’s
Department of Surgery, and Dan Lacroix, project
manager at the LOEX research center (St-
Sacrement Hospital) in Quebec. We also wish to
thank Guillaume Lalande, Rosalie Pelletier, and
Catherine Tremblay, M.Sc. students, for their
support and contribution to this work.
2009-06-22
Trending Topic
Cardiovascular diseases are the most common cause of mortality and morbidity in adults worldwide.1Â Coronary angiography (CAG) is the gold standard method for evaluating atherosclerotic coronary artery disease (CAD).2Â It is conventionally performed via the trans-femoral (TF) route. Recently, however, the trans-radial (TR) route has become the preferred way.3Â The TR route offers better procedure comfort, shorter hospitalization […]
We are sorry to announce the death of one of our valued editorial board members, Dr Richard Heuser (November 17, 1950–May 23, 2024). Richard R Heuser, MD, FACC, FACP, FESC, MSCAI, was an internationally recognized cardiologist, inventor, educator and author, and was a ...
Welcome to the summer issue of Heart International. We are excited to present a collection of insightful articles that delve into various aspects of cardiovascular health and related interventions. This issue encompasses a wide array of topics, from novel treatment ...
Clinically relevant tricuspid regurgitation (TR) is a common disorder, affecting approximately 4% of people 75 years of age or older.1Â If left untreated, severe TR results in volume overload and right ventricular remodelling. This eventually leads to symptomatic right-sided heart failure, along ...
In this issue of Heart International, we are delighted to present a collection of insightful articles that encompass a wide spectrum of topics within the field of cardiovascular medicine. As we navigate the landscape of cardiovascular disease, heart failure, preventative ...
For decades, right ventricular pacing (RVP) has been the leading pacing technique and has been proven to be effective in treating patients with symptomatic bradycardia. However, dyssynchrony caused by non-physiological ventricular activation results in pacing-induced cardiomyopathy occurs in approximately 15% of ...
Welcome to the latest issue of Heart International. This edition includes a range of articles on topics showcasing the latest advances in our understanding and treatment of cardiovascular disease. We begin with focus on the hereditary cardiac disorder, hypertrophic cardiomyopathy, ...
A significant proportion of patients with atrial fibrillation (AF) who have a high stroke risk are currently being treated with oral anticoagulation (OAC), including direct oral anticoagulants (DOACs) and vitamin K inhibitors (VKAs).1Â It is well known that the increased ...
The American Diabetes Association (ADA) defines prediabetes as glycated haemoglobin (HbA1c) 5.7–6.4% or fasting plasma glucose (FPG) 100–125 mg/dL or 5.6–6.9 mmol/L.1 Patients with prediabetes have up to a 70% chance of developing diabetes and a two-fold higher risk of cardiovascular ...
Mitral valve (MV) disease includes either mitral regurgitation or mitral stenosis or both. The incidence and prevalence of valvular heart disease is increasing with the increasing population age. Degenerative MV disease poses a global burden with a prevalence of 18.1 million ...
Welcome to the latest issue of Heart International. Cardiovascular science continues to evolve at an impressive rate, and the range of articles presented here highlights cutting-edge technology and innovation within cardiology. We begin with a commentary by Divaka Perera on ...
Welcome to the latest issue of Heart International. We are delighted to bring you another excellent issue, full of the varied and expert articles that you can expect from our authors. We begin with some exciting news. We are delighted ...
Tricuspid regurgitation (TR) is a complex disease with several independent causes. Consequently, outcomes and response to therapy vary widely. Severe or progressive TR often results in gradual right ventricular (RV) failure and is associated with poor long-term outcomes.1Â Most cases ...
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.